YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DR26FCFK5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,676
Award facts
- Contract value 100% obligated
- $55,676.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,676 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation, indicating the contractor won based on competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a regional prime vendor supplier for Department of Defense pharmaceutical needs through December 31, 2036.
DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military healthcare pharmaceutical supply chain, with recent delivery orders spanning oncology treatments, biologics, vaccines, and routine pharmaceuticals. The PPV-G GEN V initiative represents part of a broader $30.3 billion Defense Logistics Agency acquisition strategy designed to provide recurring pharmaceutical and medical supply support to military healthcare facilities worldwide. As the sole awardee on this delivery order with no identified subcontractors, DMS Pharmaceutical Group maintains direct responsibility for fulfilling the yellow fever vaccine requirements specified under this firm fixed-price agreement.
Quick answers
Who was awarded contract SPE2DR26FCFK5?
SPE2DR26FCFK5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FCFK5 worth?
The government has obligated $55,676 on SPE2DR26FCFK5.
Is contract SPE2DR26FCFK5 an order under another contract?
Yes. SPE2DR26FCFK5 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFK5 competed?
The extent of competition for SPE2DR26FCFK5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award